Source: BIOSPACE

Bolton Medical: Bolton Medical Announces The First Patient Treated With The New TREO Abdominal Stent-Graft System

SUNRISE, Fla., Oct. 16, 2015 /PRNewswire/ --Bolton Medical, a subsidiary of the WerfenLife Company, announced the first commercial implant of the TREO Abdominal Stent-Graft System by Professor Giovanni Torsello, MD, Director of the Center for Vascular and Endovascular Surgery at...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Paul Kuznik's photo - CEO of Bolton Medical

CEO

Paul Kuznik

CEO Approval Rating

82/100

Read more